“Evaluation of the CRISPR/Cas9 system as genome editing platform for the Mucopolysaccharidosis IV A using a strategy for induction of higher homologous recombination frequency” (2025) Universitas Scientiarum, 30, pp. 82–106. doi:10.11144/.